1.
Methods Mol Biol
; 2709: 263-276, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37572287
RESUMO
RNA nanoparticles are promising therapeutic platforms to improve radiotherapy since they can be functionalized with multiple small interfering RNAs (RNAi) to simultaneously silence critical radioresistance genes. Here we describe the transfer of RNA rings to mammalian cancer cells through reverse transfection, followed by in vitro irradiation and biological assays as surrogates' endpoints for radiotherapy efficacy.